Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Defluorodearomatization: A Photocatalytic Birch-Like Reduction That Enables C-C Bond Formation and Provides Access to Unnatural Cannabinoids.
J Org Chem. 2021 Jun 18;86(12):7928-7945. doi: 10.1021/acs.joc.1c00169. Epub 2021 Jun 2.
J Org Chem. 2021.
PMID: 34076434
Free PMC article.
Photosubstitution in Dicyanobenzene-based Photocatalysts.
Grotjahn S, König B.
Grotjahn S, et al.
Org Lett. 2021 Apr 16;23(8):3146-3150. doi: 10.1021/acs.orglett.1c00836. Epub 2021 Apr 6.
Org Lett. 2021.
PMID: 33821659
Item in Clipboard
Reactivity of Superbasic Carbanions Generated via Reductive Radical-Polar Crossover in the Context of Photoredox Catalysis.
Grotjahn S, Graf C, Zelenka J, Pattanaik A, Müller L, Kutta RJ, Rehbein J, Roithová J, Gschwind RM, Nuernberger P, König B.
Grotjahn S, et al.
Angew Chem Int Ed Engl. 2024 Apr 24;63(18):e202400815. doi: 10.1002/anie.202400815. Epub 2024 Mar 15.
Angew Chem Int Ed Engl. 2024.
PMID: 38408163
Item in Clipboard
Effects of Empagliflozin on Fluid Overload, Weight, and Blood Pressure in CKD.
Mayne KJ, Staplin N, Keane DF, Wanner C, Brenner S, Cejka V, Stegbauer J, Judge PK, Preiss D, Emberson J, Trinca D, Dayanandan R, Lee R, Nolan J, Omata A, Green JB, Cherney DZI, Hooi LS, Pontremoli R, Tuttle KR, Lees JS, Mark PB, Davies SJ, Hauske SJ, Steubl D, Brückmann M, Landray MJ, Baigent C, Haynes R, Herrington WG; EMPA-KIDNEY Collaborative Group.
Mayne KJ, et al.
J Am Soc Nephrol. 2024 Feb 1;35(2):202-215. doi: 10.1681/ASN.0000000000000271. Epub 2023 Dec 12.
J Am Soc Nephrol. 2024.
PMID: 38082486
Free PMC article.
Clinical Trial.
Item in Clipboard
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
EMPA-KIDNEY Collaborative Group.
EMPA-KIDNEY Collaborative Group.
Lancet Diabetes Endocrinol. 2024 Jan;12(1):51-60. doi: 10.1016/S2213-8587(23)00322-4. Epub 2023 Dec 4.
Lancet Diabetes Endocrinol. 2024.
PMID: 38061372
Free article.
Clinical Trial.
Item in Clipboard
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
EMPA-KIDNEY Collaborative Group.
EMPA-KIDNEY Collaborative Group.
Lancet Diabetes Endocrinol. 2024 Jan;12(1):39-50. doi: 10.1016/S2213-8587(23)00321-2. Epub 2023 Dec 4.
Lancet Diabetes Endocrinol. 2024.
PMID: 38061371
Free PMC article.
Clinical Trial.
Item in Clipboard
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group; Herrington WG, Staplin N, Wanner C, Green JB, Hauske SJ, Emberson JR, Preiss D, Judge P, Mayne KJ, Ng SYA, Sammons E, Zhu D, Hill M, Stevens W, Wallendszus K, Brenner S, Cheung AK, Liu ZH, Li J, Hooi LS, Liu W, Kadowaki T, Nangaku M, Levin A, Cherney D, Maggioni AP, Pontremoli R, Deo R, Goto S, Rossello X, Tuttle KR, Steubl D, Petrini M, Massey D, Eilbracht J, Brueckmann M, Landray MJ, Baigent C, Haynes R.
The EMPA-KIDNEY Collaborative Group, et al.
N Engl J Med. 2023 Jan 12;388(2):117-127. doi: 10.1056/NEJMoa2204233. Epub 2022 Nov 4.
N Engl J Med. 2023.
PMID: 36331190
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite